Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 AUD | -4.35% | 0.00% | +10.00% |
Mar. 08 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
Feb. 28 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.4K 2.28K | Sales 2023 | 42.02K 28.12K | Capitalization | 23.4M 15.66M |
---|---|---|---|---|---|
Net income 2022 | -1M -669K | Net income 2023 | -2M -1.34M | EV / Sales 2022 | 1,775 x |
Net cash position 2022 | 4.24M 2.84M | Net cash position 2023 | 4.11M 2.75M | EV / Sales 2023 | 459 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-9.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.45% |
1 day | -4.35% | ||
Current month | +10.00% | ||
3 months | +10.00% | ||
6 months | -8.33% | ||
Current year | +10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daya Uka
DFI | Director of Finance/CFO | - | 15-12-31 |
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-18 |
Chief Operating Officer | - | 21-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hainsworth
CHM | Chairman | 50 | 22-10-30 |
Bradley Dilkes
BRD | Director/Board Member | 39 | 22-10-30 |
Bradley Latham
BRD | Director/Board Member | 62 | 23-07-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.011 | -4.35% | 270,706 |
24-05-16 | 0.0115 | +4.55% | 569,078 |
24-05-15 | 0.011 | -4.35% | 18,181 |
24-05-14 | 0.0115 | +4.55% | 116,983 |
24-05-13 | 0.011 | 0.00% | 2,015,382 |
Delayed Quote Australian S.E., May 17, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+10.00% | 12.41M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 1AI Stock